Skip to main content
. 2009 Aug;15(8):1260–1264. doi: 10.3201/eid1508.081187

Figure 2.

Figure 2

Increased prevalence in the erm(B) + mef(A) macrolide resistance genotype from year 1 (2000–2001) to year 6 (2005−2006), Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin, United States surveillance study.